back to conferences

Global NASH Congress 2021


April 28-19, 2021



In 2021 the Global NASH conference will once again explore the advances being made in research and development in pathogenesis, diagnosis and treatment of non-alcoholic steatohepatitis (non-alcoholic fatty liver disease). A multi-disciplinary speaker panel will give their insights on these developments as well as reporting on clinical trials.

This program creates a collaborative environment to foster the creation of enduring relationships across the full range of disciplines engaged in NASH research & drug discovery and development.

  • Learn how to integrate NAFLD Screening into secondary and tertiary care
  • Discover the regulatory pathways for approval of biomarkers in NAFLD patients
  • Review the current and potential biomarkers for staging
  • Investigate if targeting fructose metabolism offers a NAFLD/NASH therapy
  • Hear how belapectin, a galectin-3 (Gal-3) inhibitor, is in development for the prevention of oesophagal varices in patients with NASH cirrhosis
  • Explore the Epidemiology of NAFLD

To learn more about how Simoa technology can support the study of NASH, please contact

For more information on the congress, please visit the event website.